Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial

Publication

Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial

Journal Paper/Review - Feb 5, 2020

Stöhr Robert, Sanders-van Wijk Sandra, Pfisterer Matthias, Jeker Urs, Schuh Alexander, Leibundgut Gregor, Maeder Micha, Heine Gunnar H, Brandenburg Vincent M, Brunner-La Rocca Hans-Peter

Stöhr, Robert

Brandenburg, Vincent M

Heine, Gunnar H

Maeder, Micha

attending physician
Kardiologie · Dept. I

190

Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial

Stöhr, Robert

Brandenburg, Vincent M

Heine, Gunnar H

Maeder, Micha

Leibundgut, Gregor

Schuh, Alexander

Jeker, Urs

Pfisterer, Matthias

Sanders-van Wijk, Sandra

Brunner-La Rocca, Hans-Peter